Florida, December 27, 2017: The Global Active Pharmaceutical Ingredient (API) Market is expected to exceed more than US$ 219.60 Billion by 2023 at a CAGR of 6.3% in the given forecast period.

    The Global Active Pharmaceutical Ingredient (API) Market is segmented on the lines of its manufacturing process, API type, therapeutic area, drug type and regional. Based on manufacturing process segmentation it covers captive, contract. Based on API type segmentation it covers synthetic chemical API, biological API. Based on therapeutic area segmentation it covers cardiovascular disorders, metabolic disorders, neurological disorders, oncology, musculoskeletal disorders, NSAIDs, other therapeutics uses.  Based on drug type segmentation it covers branded prescription drugs, generic prescription drugs, OTC prescription drugs. The Global Active Pharmaceutical Ingredient (API) Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

    This report provides:

    1) An overview of the global market for Global Active Pharmaceutical Ingredient (API) Market and related technologies.
    2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2023.
    3) Identifications of new market opportunities and targeted promotional plans for Global Active Pharmaceutical Ingredient (API) Market.
    4) Discussion of research and development, and the demand for new products and new applications.
    5) Comprehensive company profiles of major players in the industry.

    You Can Find Full Report @: https://www.marketresearchengine.com/active-pharmaceutical-ingredient-market

    Active Pharmaceutical Ingredient (API) is the part of any drug product. Pharmaceutical drugs might be available in type of capsules or tablets yet their genuine components are a long way from homogenous. Active Pharmaceutical Ingredient (API) is known as that part of the chemical included in the drugs which treats the cause and that actually works on the condition. Contents in drugs is not static it may contain one or more API and according to the dosage or prescription it will differ from person to person. Pharmaceutical technologists are prevalently possessed with the creation of different dose structures, for example, tablets, pastilles or dragees. The enhancing access to healthcare with the fast penetration of technology and different advancements in the healthcare segment.

    The major driving factors of Global Active Pharmaceutical Ingredient (API) Market are as follows:

    • Growing in healthcare expenditure
    • Advancements in the technology of API manufacturing
    • Rapidly increase  aging  population
    • Increasing Importance of Generics
    • Increase in abbreviated new drug applications (ANDA)
    • Growth in Incidence of Chronic Diseases

    The restraining factors of Global Active Pharmaceutical Ingredient (API) Market are as follows:

    • Drug price control policies across different economies are unfavorable
    • Strict regulatory requirements
    • High production cost

    The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Allergan plc, BASF SE, Boehringer Ingelheim Group, Cambrex Corporation, Dr. Reddy’s Laboratories Ltd., Lonza Group, Mylan, Inc., Sandoz (Novartis AG), Pfizer, Inc., Teva Pharmaceutical Industries Ltd., and WuXiApptec. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

    Request Sample Report here @: https://www.marketresearchengine.com/active-pharmaceutical-ingredient-market

     

    Table of Contents

    1 INTRODUCTION

    2 Research Methodology

    2.1 Market Size Estimation
    2.2 Market Breakdown and Data Triangulation
    2.3 Key Data From Secondary Sources
    2.4 Key Data From Primary Sources
    2.5 Key Industry Insights
    2.6 Assumptions for the Study

    3 Executive Summary

    4 Premium Insights

    4.1 Active Pharmaceutical Ingredients Market Overview
    4.2 Active Pharmaceutical Ingredients Market, By Type of Manufacturer
    4.3 Active Pharmaceutical Ingredients Market, By Therapeutic Area
    4.4 Biotech Active Pharmaceutical Ingredients Market, By Product
    4.5 Active Pharmaceutical Ingredients Market, By Type of Drug
    4.6 Active Pharmaceutical Ingredients Market: Geographic Snapshot

    5 Market Overview

    6 Active Pharmaceutical Ingredients Market, By Type

    7 Active Pharmaceutical Ingredients Market, By Type of Manufacturer

    8 Active Pharmaceutical Ingredients Market, By Type of Synthesis

    9 Active Pharmaceutical Ingredients Market, By Type of Drug

    10 Active Pharmaceutical Ingredients Market, By Therapeutic Application

    11 Active Pharmaceutical Ingredients Market, By Region

    12 Competitive Landscape

    13 Company Profiles

    13.1 Introduction

    13.2 Pfizer, Inc.

    13.3 Novartis International AG

    13.4 Sanofi

    13.5 Boehringer Ingelheim

    13.6 Bristol-Myers Squibb

    13.7 Teva Pharmaceutical Industries Ltd.

    13.8 ELI Lilly and Company

    13.9 Glaxosmithkline PLC

    13.10 Merck & Co., Inc.

    13.11 Abbvie Inc.
    Media Contact

    Company Name: Market Research Engine

    Contact Person: John Bay

    Email: john@marketresearchengine.com

    Phone: +1-855-984-1862

    Country: United States

    Website: https://www.marketresearchengine.com/

     

    Source: http://www.financeswire.com/global-active-pharmaceutical-ingredient-api-market-to-cross-us-219-00-billion-by-2023